Reaction Details Report a problem with these data
Target
Oxysterols receptor LXR-beta
Ligand
BDBM50509328
Substrate
n/a
Meas. Tech.
ChEMBL_1837940 (CHEMBL4338073)
IC50
>10000±n/a nM
Citation
 Marcoux, D; Duan, JJ; Shi, Q; Cherney, RJ; Srivastava, AS; Cornelius, L; Batt, DG; Liu, Q; Beaudoin-Bertrand, M; Weigelt, CA; Khandelwal, P; Vishwakrishnan, S; Selvakumar, K; Karmakar, A; Gupta, AK; Basha, M; Ramlingam, S; Manjunath, N; Vanteru, S; Karmakar, S; Maddala, N; Vetrichelvan, M; Gupta, A; Rampulla, RA; Mathur, A; Yip, S; Li, P; Wu, DR; Khan, J; Ruzanov, M; Sack, JS; Wang, J; Yarde, M; Cvijic, ME; Li, S; Shuster, DJ; Borowski, V; Xie, JH; McIntyre, KW; Obermeier, MT; Fura, A; Stefanski, K; Cornelius, G; Hynes, J; Tino, JA; Macor, JE; Salter-Cid, L; Denton, R; Zhao, Q; Carter, PH; Dhar, TGM Rationally Designed, Conformationally Constrained Inverse Agonists of ROR?t-Identification of a Potent, Selective Series with Biologic-Like in Vivo Efficacy. J Med Chem 62:9931-9946 (2019) [PubMed]  Article 
Target
Name:
Oxysterols receptor LXR-beta
Synonyms:
LXRB | Liver X receptor beta (NR1H2) | Liver X, LXR beta | NER | NR1H2 | NR1H2_HUMAN | Nuclear receptor NER | UNR | Ubiquitously-expressed nuclear receptor
Type:
Enzyme Catalytic Domain
Mol. Mass.:
50978.79
Organism:
Homo sapiens (Human)
Description:
P55055
Residue:
460
Sequence:
MSSPTTSSLDTPLPGNGPPQPGAPSSSPTVKEEGPEPWPGGPDPDVPGTDEASSACSTDWVIPDPEEEPERKRKKGPAPKMLGHELCRVCGDKASGFHYNVLSCEGCKGFFRRSVVRGGARRYACRGGGTCQMDAFMRRKCQQCRLRKCKEAGMREQCVLSEEQIRKKKIRKQQQESQSQSQSPVGPQGSSSSASGPGASPGGSEAGSQGSGEGEGVQLTAAQELMIQQLVAAQLQCNKRSFSDQPKVTPWPLGADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIMLLETARRYNHETECITFLKDFTYSKDDFHRAGLQVEFINPIFEFSRAMRRLGLDDAEYALLIAINIFSADRPNVQEPGRVEALQQPYVEALLSYTRIKRPQDQLRFPRMLMKLVSLRTLSSVHSEQVFALRLQDKKLPPLLSEIWDVHE
  
Inhibitor
Name:
BDBM50509328
Synonyms:
CHEMBL4452650
Type:
Small organic molecule
Emp. Form.:
C30H30F7NO5S
Mol. Mass.:
649.617
SMILES:
[H][C@@]12CCc3cc(ccc3[C@@]1(CCN2C(=O)[C@H]1CC[C@@H](CC1)C(O)=O)S(=O)(=O)Cc1ccccc1)C(F)(C(F)(F)F)C(F)(F)F |r,wU:16.18,wD:19.25,1.0,10.28,(38.9,-47.28,;37.57,-48.06,;37.57,-46.51,;36.22,-45.72,;34.88,-46.5,;33.55,-45.74,;32.22,-46.51,;32.22,-48.05,;33.55,-48.82,;34.88,-48.06,;36.22,-48.83,;36.53,-50.35,;38.08,-50.52,;38.72,-49.11,;40.23,-48.8,;40.71,-47.34,;41.25,-49.95,;42.74,-49.63,;43.77,-50.78,;43.29,-52.25,;41.78,-52.56,;40.75,-51.41,;44.31,-53.4,;43.83,-54.86,;45.82,-53.08,;35.12,-49.92,;34.02,-51.01,;33.62,-49.51,;35.5,-51.41,;34.4,-52.49,;32.93,-52.07,;31.83,-53.15,;32.21,-54.64,;33.71,-55.05,;34.8,-53.97,;30.89,-45.74,;29.55,-44.97,;29.55,-46.51,;28.22,-45.74,;29.55,-48.05,;28.21,-47.27,;30.89,-44.2,;32.22,-43.43,;29.55,-43.43,;30.88,-42.66,)|
Structure:
Search PDB for entries with ligand similarity: